ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1289

Gout Education for Primary Care Providers: A Scoping Review

Madeline O’Sullivan1, Michael Battistone2, Gary Kunkel3, Kalani Raphael1, Lydia Howes4, Naomi Schlesinger1 and Andrea Barker2, 1University of Utah, Salt Lake City, UT, 2Salt Lake City VA, Salt Lake City, UT, 3University of Utah and George E Wahlen VAMC, Salt Lake City, UT, 4University of Utah, 10 N 1900 E, UT

Meeting: ACR Convergence 2024

Keywords: education, medical, gout

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Professional Education Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Gout is the most common inflammatory arthritis. Despite widespread availability of effective therapies and management guidelines from ACR and EULAR, many gout patients remain inadequately treated. Given the high prevalence of gout coupled with a limited rheumatology workforce, the diagnosis and management of gout often falls to primary care clinicians (PCCs). To better prepare PCCs for this growing role, numerous calls have been made for targeted continuing professional development (CPD) to guide PCCs in the optimal treatment of gout. Our aim was to conduct a scoping review to identify what literature exists regarding CPD and/or education programs for PCCs on the topic of gout.

Methods: Following the scoping review (ScR) methodology informed by Arksey and O’Malley and in collaboration with a research librarian, we developed a full ScR protocol to search databases from 2008 to present. A preliminary search of our primary database, Medline (Ovid), served as a pilot. Articles relevant to gout education for PCCs with original manuscripts available in English were included for review. We excluded those describing education for medical trainees or patients and caregivers, and independent review articles offering continuing medical education credit if these did not describe any other intervention. Each article was screened and reviewed independently by two authors and disagreements were resolved in discussion with a third author. Two authors (MO, AB) performed data extraction of each included article.

Results: Our MEDLINE search identified 134 articles for title/abstract screening, of which 8 full texts were reviewed for eligibility and 2 were identified for inclusion (Figure 1). Both articles were published in rheumatology journals from the United States (Table 1). Both included a pre/post intervention design with 1 utilizing a control group and an in-person/live educational component. One study examined post-intervention gout quality measures (proportion of patients treated, monitored, and at goal) while the other tested post-intervention diagnostic and treatment knowledge based on established guidelines (Table 2). Each paper included a description of the intervention, but neither provided details of the curriculum sufficient to inform future educational efforts.

Conclusion: While there is a well-established need for gout CPD for PCCs in the literature, these preliminary data suggest there is a lack of published education interventions. This gap is important because we have little evidence that training experiences are being examined in a way that increases our knowledge about the effectiveness of our educational innovations. PCCs are likely to continue playing an increasing role in the management of gout. Collaboration between educational leaders in rheumatology (content experts) and primary care (context experts) to co-create CPD may lead to new methods for teaching and learning tailored to PCCs, and new models of care for patients with gout. In addition to developing and implementing these programs, critical examination of educational innovations and dissemination of findings through peer-reviewed scholarship is essential.

Supporting image 1

Figure 1. PRISMA flow diagram

Supporting image 2

Table 1. Study Characteristics – General

Supporting image 3

Table 2. Study Characteristics – Educational Intervention


Disclosures: M. O’Sullivan: None; M. Battistone: None; G. Kunkel: None; K. Raphael: None; L. Howes: None; N. Schlesinger: arthrosi, 1, horizon, 1, Novartis, 1, olatec, 1, 2, ptotalix, 1, 2, shanton, 1, sobi, 1; A. Barker: None.

To cite this abstract in AMA style:

O’Sullivan M, Battistone M, Kunkel G, Raphael K, Howes L, Schlesinger N, Barker A. Gout Education for Primary Care Providers: A Scoping Review [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/gout-education-for-primary-care-providers-a-scoping-review/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/gout-education-for-primary-care-providers-a-scoping-review/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology